Naturally occurring or synthetically derived theaflavins and thearubigins are disclosed which are orally active and have novel and specific metabolic enhancing effects in humans. The inventors have discovered that theaflavins and thearubigins decrease appetite, reduce adipose tissue, increase metabolism and energy levels and protect and enhance lean body mass.